High-Grade Glioma - Pipeline Review, H2 2016

Friday, March 10, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, March 9, 2017 /PRNewswire/ -- e Glioma - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical

and Healthcare disease pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides an overview of the High-Grade Glioma (Oncology) pipeline landscape.Download the full report: https://www.reportbuyer.com/product/2577037/High­ly gra­de glio­mas
(HGG) are tumors of the cen­tral ner­vous sys­tem (CNS) that ari­sing from trans­for­med cells of the brain and spi­nal cord. Symptoms include de­ve­lop­men­tal de­lay, head­a­ches, back­a­ches, nau­sea and vo­miting, diz­zi­ness, gait dis­tur­ban­ces, im­pai­red vi­si­on, lack of con­cen­tra­ti­on, drow­si­ness, sleep dis­tur­ban­ces, Dysregulated ap­pe­ti­te, pa­ra­ly­ses and sei­zu­res. Treatment includes Chemotherapy and radiation therapy.Report HighlightsGlobal Markets Direct's Pharmaceutical and Healthcare latest pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for High-Grade Glioma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The High-Grade Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for High-Grade Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 10, 10, 3 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I and Preclinical stages comprises 2, 1 and 2 molecules, respectively.High-Grade Glioma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.Scope- The pipeline guide provides a snapshot of the global therapeutic landscape of High-Grade Glioma (Oncology).- The pipeline guide reviews pipeline therapeutics for High-Grade Glioma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.- The pipeline guide reviews key companies involved in High-Grade Glioma (Oncology) therapeutics and enlists all their major and minor projects.- The pipeline guide evaluates High-Grade Glioma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for High-Grade Glioma (Oncology)Reasons to buy- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.- Find and recognize significant and varied types of therapeutics under development for High-Grade Glioma (Oncology).- Classify potential new clients or partners in the target demographic.- Develop tactical initiatives by understanding the focus areas of leading companies.- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.- Formulate corrective measures for pipeline projects by understanding High-Grade Glioma (Oncology) pipeline depth and focus of Indication therapeutics.- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.Download the full report: https://www.reportbuyer.com/product/2577037/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/high-grade-glioma---pipeline-review-h2-2016-300421431.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook